Executive Summary

Transform internal operations in BioPharma and beyond with enterprise-ready AI assistants that empower teams and speed innovation.

The implementation led to significant reductions in document handling time, improved regulatory readiness, and increased operational capacity—paving the way for broader AI integration across the organization.

Organizational Profile

This multinational life sciences company operates across drug development, clinical research, manufacturing, and regulatory affairs. Its internal teams manage complex documentation such as clinical trial protocols, quality control reports, regulatory submissions, and standard operating procedures (SOPs). With increasing data volumes and compliance scrutiny from global health authorities, the company identified a need to automate knowledge-intensive internal processes.

Business Challenge

The organization faced growing inefficiencies and risks across its back-office and compliance operations:

  •  Siloed systems made accessing prior research, regulatory precedents, and SOPs time-consuming
  •  Manual document processing delayed activities like clinical study submissions, quality incident reviews, and vendor assessments
  •  Inconsistent interpretations of regulatory and operational guidelines across teams
  •  Limited audit trail visibility, complicating global compliance with FDA, EMA, and other authorities

These constraints slowed down time-to-decision and increased compliance exposure.

Technical Solution

The company deployed a secure, enterprise-grade AI Assistant tailored to life sciences workflows. Key components included:

  •  Generative AI (GenAI) to summarize complex documents (e.g., INDs, CAPAs), draft internal memos, and propose policy-aligned actions
  •  NLP and OCR to extract structured insights from lab reports, scanned documents, and regulatory feedback
  •  Retrieval-Augmented Generation (RAG) to answer internal queries by referencing validated sources such as SOP repositories, audit logs, and past inspection findings
  •  RPA and automation for routing exception reports, updating internal systems, and compiling submission packages
  •  Multi-model AI gateway to support use of various large language models (LLMs) while maintaining information security and model auditability
  •  Enterprise integration with document management systems (e.g., Veeva Vault, SharePoint), regulatory databases, and collaboration tools

Implementation Approach

Phase 1: Process Mapping & Stakeholder Interviews

  •  Engaged teams across Regulatory Affairs, Clinical Operations, Quality, and IT
  •  Identified high-volume, document-heavy tasks with compliance dependencies

Phase 2: Design & Architecture

  •  Defined secure AI architecture with model governance and RAG search logic
  •  Integrated internal document repositories and SOP libraries into assistant framework

Phase 3: Pilot Deployment

  •  Tested AI Assistant on regulatory response generation, SOP retrieval, and CAPA documentation
  •  Established human-in-the-loop review and feedback mechanisms

Phase 4: Enterprise Expansion

  •  Rolled out assistant capabilities to medical affairs, pharmacovigilance, and supply chain compliance
  •  Trained users in prompt design and document interaction
  •  Enabled usage analytics and feedback loops for continuous model refinement

Business Impact

  •  65% reduction in time spent compiling responses for regulatory audits and inspections
  •  30% increase in document handling capacity within compliance and QA teams
  •  100% traceability of AI-supported actions and decisions for audit readiness
  •  Improved consistency in interpretation of internal policies and external regulations
  •  Increased employee satisfaction due to AI-assisted research and reporting workflows

Strategic Significance

The Enterprise AI Assistant delivered operational and strategic benefits, including:

  •  Accelerated compliance readiness for submissions, inspections, and change controls
  •  Improved institutional memory through contextual document search and reuse of precedent
  •  Established scalable AI foundations for future digital lab, manufacturing, and post-market monitoring use cases
  •  Supported a culture of digital innovation across internal scientific and compliance functions

Looking Ahead

Following the successful deployment, the organization is expanding the AI Assistant’s reach to:

Automate pharmacovigilance case review and periodic safety update report (PSUR) drafting
Streamline medical information requests with policy-aware, RAG-backed responses
Support global labeling updates with multi-language GenAI summarization and workflow integration
Embed AI agents into laboratory information systems and clinical trial platforms for real-time support

With a strong governance framework and secure AI infrastructure in place, the company is poised to drive innovation and compliance simultaneously.

Key Takeaways

This use case demonstrates how life sciences organizations can:

Use GenAI and RAG to boost efficiency in regulated document workflows
Improve audit readiness and regulatory alignment through explainable automation
Reduce manual overhead while enhancing employee productivity
Create a scalable and compliant AI foundation across R&D, quality, and operations
Strategically deployed AI tools offer significant value for life sciences firms seeking operational excellence and regulatory agility in an increasingly complex global environment.
Next Step:

Let’s redefine what’s possible with AI-powered innovation

 

Next Step:

Let’s redefine what’s possible with AI-powered innovation